本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Trinity Biotech plc

1.00
+0.01921.96%
盘后1.010.0099+0.99%18:32 EST
成交量:4.85万
成交额:4.80万
市值:1,863.20万
市盈率:-0.55
高:1.01
开:0.9850
低:0.9507
收:0.9808
52周最高:3.44
52周最低:0.4800
股本:1,863.20万
流通股本:1,625.41万
量比:0.75
换手率:0.30%
股息:- -
股息率:- -
每股收益(TTM):-1.8319
每股收益(LYR):-1.7700
净资产收益率:-1913.45%
总资产收益率:-10.53%
市净率:-0.53
市盈率(LYR):-0.56

数据加载中...

2021/04/30

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/17

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/10/28

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/10/28

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/09/04

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/07/13

SEC问询函

CORRESP [Cover] - Correspondence
2020/06/15

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/10/16

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/20

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/08

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/05/14

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/05/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]